Life Sentence Handed Down In Fatal Counterfeit Diabetes Drug Case
This article was originally published in PharmAsia News
The Kashgar District Intermediate People's Court recently sentenced eight defendants to prison time and fines for the manufacture and sale of counterfeit "glycolipid capsules" that resulted in the deaths of two diabetic patients in 2009
You may also be interested in...
The EU’s upcoming pharma strategy offers an important opportunity for change, according to Medicines for Europe. The off-patent industry body has set out five key issues that should be priorities for the EU Commission.
The EU’s IVD Regulation is going to apply just a year later than the EU’s MDR. Where are the gaps and how can industry manage the IVD notified body shortage?
The dangers of a hard Brexit, a welcome delay to the EU Medical Devices Regulation and the impact of the coronavirus on the German OTC market all feature in this exclusive HBW Insight catch up with Germany's self-medication industry association, the BAH.